Restructurings & Charges

ICAD INC announced a restructuring with charges of approximately $0.3 million affecting detection business unit and Xoft, Inc. (approximately 28%, decreasing its headcount by approximately 23 employees).

“On March 20, 2023, iCAD, Inc. (the “Company”) committed to a restructuring plan intended to support its long term strategic goals and reduce operating expenses by further aligning its cost structure to focus on areas the Company believes are more likely to generate the best long-term results, in light of current industry and macroeconomic environments (the “RIF”). The Company plans to reduce its workforce by approximately 28%, decreasing its headcount by approximately 23 employees, predominantly from the Company’s detection business unit. Xoft, Inc., a wholly-owned subsidiary of the Company, will also furlough 12 of its employees, or approximately 50% of its workforce. The Company currently estimates it will incur one-time cash pre-tax restructuring charges of an aggregate of approximately $0.3 million in the first half of 2023 as a result of the RIF, comprised primarily of one-time severance and benefits payments, and employee-related transition costs.”

Better Therapeutics, Inc. announced a restructuring with charges of approximately $400 thousand (approximately 35% of its employees).

“On March 23 2023, Better Therapeutics, Inc. (the “Company”) announced a reduction in its workforce (the “Workforce Reduction”) of approximately 35% of its employees as part of a cost reduction initiative to improve its cash runway and focus on the long-term success of the company. The Company will complete this Workforce Reduction on March 24, 2023. The Company estimates that it will incur approximately $400 thousand in cash-based expenses related to severance and benefits in the second quarter of 2023.”

Wejo Group Ltd announced a restructuring with charges of Reduction in force of approximately 40 employees affecting global (approximately 40 employees).

“On March 22, 2023, the Board of Directors of the Company approved a plan to reduce the Company’s workforce by approximately 40 employees, representing approximately 16% of the Company’s total current global workforce.”

CIMPRESS plc announced a restructuring with charges of approximately $25 million to $27 million affecting Vista business and Cimpress central teams (approximately 500 team members).

“these plans to generate about $100 million in annualized pre-tax cost savings. Cimpress estimates it will incur an aggregate pre-tax restructuring charge of approximately $25 million to $27 million, which includes $22 million to $24 million of severance-related expense and approximately $3 million of other restructuring charges. Of the total estimated”

FIREFLY NEUROSCIENCE, INC. announced a impairment with charges of from $7,800,000 to $8,200,000 affecting Gray Matters, Inc..

“Item 2.06 Material Impairment In connection with the Company’s audit process for the fiscal year ended December 31, 2022 and the proposed terms of the prospective transaction regarding Gray Matters, Inc., the Company’s chief financial officer concluded that a material charge is required relating to the assets of Gray Matters, Inc., consisting of goodwill, intangible assets, capitalized software costs and right of use assets. The Company anticipates the impairment charge will approximate from $7,800,000 to $8,200,000.”

OLIN Corp announced a restructuring with charges of approximately $57 million affecting Olin’s Cumene facility in Terneuzen, Netherlands and the solid epoxy resin production at its facilities in Gumi, South Korea and Guaruja, Brazil.

“on March 21, 2023, management of Olin Corporation (“Olin”) approved a plan to cease operations at Olin’s Cumene facility in Terneuzen, Netherlands and the solid epoxy resin production at its facilities in Gumi, South Korea and Guaruja, Brazil. Olin plans to cease operations by March 31, 2023. In the first quarter of 2023, Olin expects to incur approximately $57 million of restructuring charges under this plan, of which approximately $15 million of these restructuring charges represent non-cash asset impairment of equipment and facility.”

Evofem Biosciences, Inc. announced a restructuring with charges of aggregate pre-tax charges of approximately $0.1 million in connection with the reduction in force, primarily consisting of notice period and severance payments, affecting Company-wide (office and management positions) (39% reduction of payroll expenses; elimination of eight office and management positions including Chief Commercial Offic).

“On March 20, 2023 the Board of Directors of Evofem Biosciences, Inc. (the “Company”) approved a reduction in force (“RIF”) intended to conserve the Company’s current cash resources and manage operating expenses. The Company will reduce its current workforce resulting in an overall 39% reduction of payroll expenses including (i) salary cuts for certain employees, (ii) elimination of eight office and management positions including the elimination of the Chief Commercial Officer role effective March 17, 2023; and (iii) reduction of the Chief Executive Officer’s salary by 40%. The Company expects annualized future cost savings from the reduction in force to be approximately $4.3 million, which the Company intends to use to support its operations. The Company estimates that it will incur aggregate pre-tax charges of approximately $0.1 million in connection with the reduction in force, primarily consisting of notice period and severance payments, employee benefits and related costs. The Comp”

SIGMATRON INTERNATIONAL INC announced a impairment with charges of approximately $9.8 million affecting Pet Tech Segment.

“Accordingly, a non-cash pre-tax goodwill impairment charge of approximately $13.3 million and a non-cash intangible assets impairment charge of approximately $9.8 million would be recorded for the Company’s Pet Tech Segment for the quarter ended January 31, 2023.”

SIGMATRON INTERNATIONAL INC announced a impairment with charges of approximately $13.3 million affecting Pet Tech Segment.

“Accordingly, a non-cash pre-tax goodwill impairment charge of approximately $13.3 million and a non-cash intangible assets impairment charge of approximately $9.8 million would be recorded for the Company’s Pet Tech Segment for the quarter ended January 31, 2023.”

HOOKER FURNISHINGS Corp announced a restructuring with charges of approximate $34 million non-cash charge affecting Home Meridian operating segment (Accentrics Home e-commerce business unit and Prime Resources International business unit).

“On March 14, 2023, Hooker Furnishings Corporation (the “Company”), approved a plan to exit the Accentrics Home (“ACH”) e-commerce business unit of its Home Meridian operating segment (“Home Meridian” or “HMI”) along with repositioning the Prime Resources International (“PRI”) business unit as a direct-container only business model. Concurrent with that exit, the Company expects to record an approximate $34 million non-cash charge related to the exit.”

ALLIED HEALTHCARE PRODUCTS INC announced a restructuring with charges of $17.5 million affecting St. Louis, Missouri manufacturing facilities and administrative offices (reduction in force that will impact employees of its St. Louis, Missouri manufacturing facilities and certain employees).

“union employees, which would have triggered withdrawal liabilities owed to certain multiemployer pension plans which were most recently estimated by such pension plans to be $17.5 million. On March 16, 2023, the Company announced that its restructuring efforts have resulted in the retention of 72 employees at its St. Louis headquarters location, including 37 union”

Leafly Holdings, Inc. /DE announced a restructuring with charges of approximately $0.7 million (approximately 41 employees).

“to be substantially completed by the end of the first quarter 2023. The Company currently estimates it will incur a one-time cash pre-tax restructuring charge of approximately $0.7 million in the first quarter of 2023, as a result of the Restructuring Plan, comprised primarily of one-time severance and other employee-related termination benefits. Estimated amounts”

Alcoa Corp announced a restructuring with charges of approximately $120 million affecting Intalco aluminum smelter (19 employees).

“to prepare the site for potential redevelopment will begin immediately. The Company will record restructuring and related charges in the first quarter of 2023 of approximately $120 million (pre- and after-tax), or $0.67 per share, related to the permanent closure of the Smelter. These charges include: approximately $17 million of asset impairments; approximately”

TE Connectivity plc announced a restructuring with charges of approximately $250 million affecting Transportation Solutions, Industrial Solutions and Communications Solutions segments (primarily comprised of employee related termination benefits).

“On March 16, 2023, the Board of Directors of TE Connectivity Ltd. (the “Company”) approved incremental restructuring actions to broaden the scope of its fiscal 2023 cost structure initiatives across the Transportation Solutions, Industrial Solutions and Communications Solutions segments. The Company expects to incur total restructuring charges, which are primarily comprised of employee related termination benefits, of approximately $250 million during fiscal year 2023, of which $104 million was incurred during the first three months of fiscal 2023.”

Ontrak, Inc. announced a restructuring with charges of approximately $0.3 million (approximately 19% of the Company’s employee positions were eliminated).

“on March 9, 2023, the Company implemented additional headcount reductions wherein approximately 19% of the Company’s employee positions were eliminated. These headcount reductions are expected to result in a reduction of approximately $2.7 million of the Company’s annual compensation costs. The Company estimates one-time costs of approximately $0.3 million of termination benefits to the impacted employees, including severance payments and benefits. The headcount reductions were completed by March 10, 2023.”

Neurogene Inc. announced a restructuring with charges of $2.5 million and $3.0 million (approximately 70%).

“On March 6, 2023, the Board of Directors of Neoleukin Therapeutics, Inc. (the "Company") approved a reduction in force of the Company's workforce by approximately 70% and a re-prioritization of the Company’s focus to seek strategic alternatives to maximize shareholder value (the "Restructuring Plan"). The Company's current best estimate of costs it will incur for the Restructuring Plan total between $2.5 million and $3.0 million”

Bakkt, Inc. announced a restructuring with charges of approximately $3.7 - $4.1 million (approximately 16% of the Company’s non-call center, full-time workforce (49 employees)).

“force were notified of the reduction on March 9, 2023 and will exit the Company in the first quarter of 2023. The Company estimates that it will incur expenses of approximately $3.7 - $4.1 million related to the reduction in force, substantially all of which are related to employee severance and benefits costs and will be recognized in the first quarter of”

SURGALIGN HOLDINGS, INC. announced a restructuring with charges of approximately $12.5—$15.5 million affecting companywide (reduction in force of approximately 20%).

“underway and is expected to be finished by the middle of 2023. As part of this product rationalization, the Company expects to incur an inventory write down of approximately $12.5m - $15.5 million in its fourth quarter of 2022 for the period ended December 31, 2022. All other charges and costs disclosed within the November 9, 2022, Form 8-K have been”

Camping World Holdings, Inc. announced a impairment with charges of between $11 million and $16 million affecting Active Sports, LLC, a specialty products retail business.

“assets associated with the Active Sports business. The Company currently estimates the total impairment charges associated with these restructuring activities to be between $11 million and $16 million which includes property and equipment, operating lease assets, and intangibles. The Company expects that none of the foregoing impairment charges will directly”

Coherus Oncology, Inc. announced a restructuring with charges of approximately $3.4 million (approximately 60 full-time and part-time employees).

“On March 3, 2023, the Company committed to a plan to reduce its workforce (the “Plan”) by approximately 20% to focus resources on strategic priorities including the commercialization of its diversified product portfolio and development of innovative immuno-oncology product candidates. The Company initiated a reduction in force impacting approximately 60 full-time and part-time employees effective March 10, 2023 for most employees. One-time restructuring charges associated with the reduction in force are expected to be approximately $3.4 million, primarily consisting of personnel expenses such as salaries, one-time severance payments, and other benefits.”

Embark Technology, Inc. announced a restructuring with charges of approximately $7 to $11 million (approximately 230 employees).

“On March 1, 2023, the Board of Directors of Embark Technology, Inc. (the “Company”) approved a reduction in the Company’s current workforce by approximately 230 employees. The decision was based on cost-reduction initiatives intended to reduce operating expenses. The Company currently estimates that it will incur charges of approximately $7 to $11 million in connection with the reduction in force, primarily consisting of notice period and severance payments, employee benefits, equipment costs and related costs, and noncash expenses associated with vesting of share-based awards.”

PLAYSTUDIOS, Inc. announced a restructuring with charges of The Plan includes a reduction of the Company’s current total global workforce by approximately 14 percent. The Company expects to substantially complete the per affecting global workforce (approximately 14 percent).

“On February 28, 2023, PLAYSTUDIOS, Inc. (the “Company”) initiated an internal reorganization plan (the “Plan”) which is intended to enhance efficiency and reduce operating expenses. The Plan includes a reduction of the Company’s current total global workforce by approximately 14 percent. The Company expects to substantially complete the personnel reduction by the end of the second quarter of fiscal year 2023, but the timing of certain reductions will vary based on job function and location, including local legal requirements. The Company estimates that it will incur approximately $4.5 million to $5.5 million in charges in connection with the Plan, which will be substantially incurred in the first and second quarters of fiscal year 2023.”

NORDSTROM INC announced a restructuring with charges of approximately $300 million to $350 million affecting Nordstrom Canada.

“Nordstrom expects to incur pre-tax charges of approximately $300 million to $350 million in the first quarter of 2023, the substantial majority of which are anticipated to be non-cash charges, including an estimate for the impairment of the Nordstrom Canada investment and an estimate of certain claims that may be asserted against Nordstrom or its subsidiaries as a result of the wind-down of Nordstrom Canada’s operations.”

Zscaler, Inc. announced a restructuring with charges of approximately $8.0 million to $10.0 million (approximately 3%).

“3%. The reduction in workforce is expected to be substantially complete by the end of fiscal 2023. The Company expects to incur aggregate non-recurring charges of approximately $8.0 million to $10.0 million, consisting primarily of employee severance and benefit costs associated with the restructuring. The Company expects that most of these charges will be cash”

Wheels Up Experience Inc. announced a restructuring with charges of approximately $14 million in total pre-tax charges affecting areas of the business that do not directly impact the Company's operations or its customers’ experience (headcount reductions in several areas of the business).

“in the fourth quarter of 2022 (the “Q4 Actions”) prior to the Company’s commitment to taking the actions announced today. The Company estimates that it will incur approximately $14 million in total pre-tax charges in connection with the Plan, approximately $7 million of which were incurred to-date and in connection with the Q4 Actions, and approximately $7 million”

Sonder Holdings Inc. announced a restructuring with charges of $2 million to $3 million affecting corporate roles (approximately 100 corporate roles, or 14% of the corporate workforce).

“the reduction in force to be substantially complete by the end of the first quarter of 2023. Total costs and cash expenditures for the reduction in force are estimated at $2 million to $3 million, substantially all of which are related to employee severance and benefits costs and will be recognized in the first quarter of 2023. The Company expects to pay the”

Aptinyx Inc. announced a restructuring with charges of approximately $1.4 million (approximately 60%).

“On February 26, 2023, the Board of Directors (the “Board”) of Aptinyx, Inc. (the “Company”) approved a restructuring plan (the “Plan”) to reduce the Company’s operating costs and better align its workforce with the needs of its business. Under the Plan, the Company is reducing its workforce by approximately 60%, to be substantially completed by March 3, 2023. The Company expects to incur estimated severance and related costs of approximately $1.4 million, which will be recorded primarily in the first quarter of 2023.”

OMNICELL, INC. announced a restructuring with charges of approximately $7.0 million of non-cash charges related to the office closures, which the company expects to incur by the end of the second quarter of fiscal 202 affecting real estate footprint.

“$17.5 million of charges in the quarter ended December 31, 2022 and expects to incur $6.0 million of charges in the quarter ended March 31, 2023 , and (ii) approximately $7.0 million of non-cash charges related to the office closures, which the company expects to incur by the end of the second quarter of fiscal 2023 consisting primarily of impairment of”

OMNICELL, INC. announced a restructuring with charges of additional incremental nonrecurring restructuring and related charges of approximately $13.0 million in 2023 affecting across many of its functions (approximately 60 additional employees).

“As a result of continued exploration of expense containment measures, on February 28, 2023, the Company committed to further reduce its headcount, as part of the Plan.”

RYAN SPECIALTY HOLDINGS, INC. announced a restructuring with charges of approximately $65 million.

“to be completed by the end of 2024. The Company currently estimates that the Program will result in cumulative pre-tax charges to its GAAP financial results of approximately $65 million which are expected to be recorded as exit and disposal activities and are broken down as follows: Program Activity Charges Operations and Technology Optimization $ 45 million”

MeridianLink, Inc. announced a restructuring with charges of approximately $2.5 million to $3.5 million (by approximately 9%).

“On February 24, 2023, the Board of Directors (the “Board”) of MeridianLink, Inc. (the “Company”) authorized a restructuring plan (the “Plan”) that is designed to consolidate the Company’s functions and investments to prioritize customer-centric areas of the Company’s organization, align teams with the Company’s highest business priorities, and improve efficiencies. The Plan includes a reduction of the Company’s current workforce by approximately 9%. The Company estimates that it will incur charges of approximately $2.5 million to $3.5 million in connection with the Plan, consisting primarily of cash expenditures and relating to employee severance payments, employee benefits, and employee transition costs.”

Eventbrite, Inc. announced a restructuring with charges of $12-20 million affecting Company (approximately 8% of existing roles out of the Company’s current workforce of 898 employees).

“The Company expects this initiative to be substantially complete by the end of the fourth quarter of 2023. The Company expects to incur total costs associated with the Plan of $12-20 million, pre-tax, primarily future cash expenditures. Of that amount, $6-12 million is related to one-time employee termination and relocation costs, and $6-8 million is”

ON24 INC. announced a impairment with charges of $1.3 million to $1.5 million affecting underutilized real estate.

“the Company currently estimates it will incur a charge of between approximately $2.8 million to $3.3 million by the end of the first quarter of 2023, which consists of $1.5 million to $1.8 million for the reduction in force in cash severance costs and a $1.3 million to $1.5 million impairment charge for underutilized real estate.”

ON24 INC. announced a restructuring with charges of $1.5 million to $1.8 million.

“the Company currently estimates it will incur a charge of between approximately $2.8 million to $3.3 million by the end of the first quarter of 2023, which consists of $1.5 million to $1.8 million for the reduction in force in cash severance costs”

ON24 INC. announced a restructuring with charges of between approximately $2.8 million to $3.3 million.

“the Company committed to a restructuring plan to reduce expenses (the “ Plan ”). In connection with the Plan, the Company currently estimates it will incur a charge of between approximately $2.8 million to $3.3 million by the end of the first quarter of 2023, which consists of $1.5 million to $1.8 million for the reduction in force in cash severance costs and a $1.3 million to $1.5 million impairment charge for underutilized real estate.”

Apexigen, Inc. announced a restructuring with charges of approximately (i) $1.1 million in employee termination costs primarily related to severance costs, which are expected to be incurred in the first and second qua (55% of its workforce).

“earlier termination, subject to certain exceptions. The total costs related to the Company’s cost-cutting measures and retention plan are estimated to be approximately (i) $1.1 million in employee termination costs primarily related to severance costs, which are expected to be incurred in the first and second quarters of 2023, and (ii) $0.6 million in employee”

Fathom Digital Manufacturing Corp announced a restructuring with charges of approximately $2.6 million affecting Texas location (reducing the Company's workforce by an additional 14%).

“On February 17, 2023, the Company committed to additional actions to continue and expand the Optimization Plan. These additional actions include closing and consolidating a location in Texas, reducing the Company's workforce by an additional 14%, and prioritizing investments and operations in line with near-term revenue generation. For committed restructuring activities under the expanded Optimization Plan, the Company now expects to incur total pre-tax restructuring charges of approximately $2.6 million”

ObsEva SA announced a restructuring with charges of approximately $1.2 million affecting its operations in Switzerland (approximately 57%).

“On February 23, 2023, the Board of Directors (the “Board”) of the Company approved a reorganization plan, to, among other things, consolidate its operations in Switzerland, where its headquarters are located. The reorganization plan is intended to preserve cash, focus resources towards the development of nolasiban, a novel, oral oxytocin receptor agonist to improve in vitro fertilization success rates, and manage out-licensed programs. As part of the reorganization, the Company reduced its overall workforce by approximately 57%, including downsizing its US-based executive management team. The Company expects to similarly propose a reduced Board at its next Annual General Meeting of Shareholders (the “AGM”). The Company is beginning the activities with respect to the reorganization plan effective immediately. As a result, the Company expects to incur restructuring charges of approximately $1.2 million attributable to cash payments primarily for notice period payments, including healthca”

EQRx, Inc. announced a restructuring with charges of approximately $4.0 million (an 18% decrease in headcount by the end of the first quarter of 2023 to approximately 300 employees).

“On February 19, 2023, the board of directors of EQRx approved a restructuring plan (the Plan) to further increase EQRx’s operational efficiencies and streamline expenses, including an 18% decrease in headcount by the end of the first quarter of 2023 to approximately 300 employees, resulting from a reduction in force as well as not filling positions following departures. These efforts are expected to result in approximately $18.0 million in annualized cash savings. One-time payments associated with the reduction in force are expected to be approximately $4.0 million.”

Jounce Therapeutics, Inc. announced a restructuring with charges of approximately $11.2 million (approximately 57% of its current employees).

“On February 22, 2023, the Company committed to a course of action that would result in a reduction in force intended to preserve the Company's current cash resources. The Company will reduce its workforce by approximately 57% of its current employees. As a result of the reduction in force, the Company estimates that it will incur aggregate pre-tax charges of approximately $11.2 million, primarily consisting of salary payable during applicable notice periods and severance, non-cash stock-based compensation expense, and other benefits.”

Rein Therapeutics, Inc. announced a restructuring with charges of approximately $1.0 to $1.1 million affecting the Company (reduce the Company’s remaining workforce from nine to three employees).

“nine to three employees. The determination to effect the workforce reduction was made in connection with the Company’s decision, further described below, to terminate its Phase 1b breast cancer trial of ALRN-6924 and further development of ALRN-6924. The workforce reduction is designed to reduce the Company’s operating expenses while the Company explores”

INFINITY PHARMACEUTICALS, INC. announced a restructuring with charges of approximately $2 million (4 positions, representing approximately 13% of the Company’s workforce).

“On February 22, 2023, the Board of Directors of the Company approved a strategic restructuring of the Company to preserve the Company’s resources upon the signing of the Merger Agreement. The Company will reduce its overall headcount by 4 positions, representing approximately 13% of the Company’s workforce, in the first quarter of 2023. The Company currently expects to incur approximately $2 million in the first quarter of 2023 in connection with this workforce reduction.”

ESCALADE INC announced a restructuring with charges of approximately $0.5 million to $1.5 million affecting manufacturing facilities in Rosarito, Mexico.

“operational efficiencies. The Company expects to incur aggregate pre-tax legal expenses, employee severance costs, transportation and other closure expenditures of approximately $0.5 million to $1.5 million in connection with winding down its Mexican operations and disposing of the real estate, building, equipment and other related assets located at these facilities.”

LENZ Therapeutics, Inc. announced a restructuring with charges of approximately $4.9 million (approximately 50%).

“Under the Plan, the Company is reducing its workforce by approximately 50%. The Company expects to incur estimated severance and related costs of approximately $4.9 million, which will be recorded primarily in the second quarter of 2023.”

Alight, Inc. / Delaware announced a restructuring with charges of approximately $140 million affecting back-office infrastructure and operating model (elimination of full-time positions).

“costs associated with technology infrastructure transformation, and elimination of full-time positions. The Company currently expects to record in the aggregate approximately $140 million in pre-tax restructuring charges over the next two years. The restructuring charges are expected to include severance charges with an estimated to range from $20 million to $30”

AVANOS MEDICAL, INC. announced a restructuring with charges of between $20.0 million and $25.0 million affecting Chronic Care and Pain franchises (between $6.0 million and $8.0 million of employee severance and benefits costs).

“The Company now estimates it will incur between $20.0 million and $25.0 million of cash expenses in connection with the Transformation Process, consisting of between $9.0 million and $12.0 million of program management consulting and employee retention expenses; between $8.0 million and $11.0 million of expenses associated with manufacturing and supply chain improvements and portfolio rationalization; and the remainder for expenses associated with organizational design and alignment and other related activities.”

authID Inc. announced a restructuring with charges of Costs associated with exit or disposal activities; one-time termination benefits affecting United States based operations (up to 15 of the Company's 21 United States based employees be terminated; 11 employees have already been given notice).

“On February 14, 2023, the Board of Directors of authID Inc. (the “Company”) resolved to implement a revised budget for 2023 in order to reduce expenses and cash requirements and as part of such revised budget decided to re-balance staffing levels to better align with the evolving needs of the Company (the “Labor Reduction Plan”). Under the Labor Reduction Plan the Company intends that up to 15 of the Company’s 21 United States based employees be terminated 11 employees have already been given notice of their termination and the remainder may be terminated over the next several months. The Company has also given termination notice to certain vendors and contractors that provide services to the Company. The Company estimates that it will be incurring costs (in consideration of releases) in the range of $0.5 million to $1.1 million in connection with the Labor Reduction Plan, which are primarily one-time termination benefits and which will result in cash expenditures by the Company in tha”

DENTSPLY SIRONA Inc. announced a restructuring with charges of up to $165 million in one-time charges, comprising $130 million in restructuring expenditures and charges, the majority of which will be expensed as cash expend affecting DENTSPLY SIRONA Inc. global business (reduction in the Company's global workforce of approximately 8% to 10%).

“savings. The Board of Directors and management of the Company developed the restructuring plan with the help of leading third party advisors. The Company expects to incur up to $165 million in one-time charges, comprising $130 million in restructuring expenditures and charges, the majority of which will be expensed as cash expenditures in 2023, primarily related to”

Tourmaline Bio, Inc. announced a restructuring with charges of approximately $2.9 million for retention, severance and other employee termination-related costs affecting workforce reduction by approximately one-third (reducing the Company's workforce by approximately one-third).

“clinical development programs and further prioritization of the Company’s resources as it assesses strategic alternatives. The Company estimates that it will incur approximately $2.9 million for retention, severance and other employee termination-related costs in the first and second quarters of 2023. The estimate of costs that the Company expects to incur and the”

Ouster, Inc. announced a restructuring with charges of approximately $27.0 million - $30.0 million of aggregate charges, which we anticipate to include $12.0 million - $13.0 million of one-time cash termination bene (approximately 180-200 employees).

“including Velodyne’s facility in India (collectively, the “Restructuring Initiatives”). The Restructuring Initiatives are expected to result in a range of approximately $27.0 million - $30.0 million of aggregate charges, which we anticipate to include $12.0 million - $13.0 million of one-time cash termination benefits, $0.5 million of facility contract in”